Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Boston Scientific treats the 1st patient in a clinical trial of its Precision neurostimulation implant in treatment of the pain associated with chronic migraine.
Ohio-based Minimally Invasive Devices lands an extra $2.5 million investment, capping a $11.5 million fundraising round.
JenaValve raises nearly $63 million for its transcatheter aortic valve implant, saying it plans to enter the TAVI markets in the U.S. and China.
Novartis confirms that 2 former employees helped a prominent Japanese cardiologist fudge numbers in the retracted Kyoto Heart Study results.
Biomet prepares to close doors on a 230-employee manufacturing facility in Switzerland, citing a global dip in medical device prices and ongoing economic challenges.
The FDA cites 4 "objectionable observations" following an inspection of Intuitive Surgical’s facilities, and the agency plans to make a follow-up visit to take a closer look at recall procedures.
The Australian health department sounds the alarm on Stryker’s Oasys Midline Occipital Plate after problems are reported in the U.S. and Belgium.